NASDAQ:SYUT Synutra International (SYUT) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free SYUT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$6.05▼$6.0550-Day Range N/A52-Week Range$3.24▼$6.05VolumeN/AAverage Volume160,650 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Synutra International alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Synutra International Stock (NASDAQ:SYUT)Synutra International, Inc. is an infant formula company in China. The Company is engaged in the production, distribution and sale of dairy-based nutritional products under the Shengyuan or Synutra line of brands. The Company operates through three segments: Nutritional Food, which includes the sale of powdered infant and adult formula products, with brands, including Super, My Angel and Dutch Cow, as well as the sale of prepared foods under the brand of Huiliduo; Nutritional Supplement, which includes the production and sale of nutritional supplements, such as chondroitin sulfate to third-parties and microencapsulated Docosahexanoic Acid and Arachidonic Acid to the nutritional food segment for use in powdered formula production, and Other Business, which includes non-core businesses, such as ancillary sales of excess or unusable ingredients and materials to industrial customers; provision of genetic diagnostic services for new born babies, and sales of cosmetics to pregnant women.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> SYUT Stock News HeadlinesJanuary 23, 2024 | usatoday.comJudge tosses wrongful death claim against Trump in Jan. 6 suitMarch 29, 2023 | abcnews.go.comPrince Harry in court for phone hacking suit vs UK tabloidApril 19, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 29, 2023 | marketwatch.comRegulatory Affairs Outsourcing Services Market Share By 2031March 1, 2023 | nypost.comBest men’s swim trunks: 30 bathing suits in every style for him in 2023February 27, 2023 | marketwatch.comStore-bought Baby Food Market Outlook and Forecast 2023 To 2028 with Top Countries DataDecember 24, 2022 | thestreet.comDel Monte Stock Pops on Acquisition OfferSee More Headlines Receive SYUT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Synutra International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryPersonal Products Current SymbolNASDAQ:SYUT CUSIP87164C10 CIK1293593 Webwww.synutra.com Phone+1-301-8403888FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesLiang ZhangChairman of the Board, Chief Executive OfficerClare CaiChief Financial OfficerBio & Compensation - Ning CaiChief Financial OfficerFeng ZhaVice President - Human Resources and AdministrationXisen MuVice President - ProductionJinrong ChenIndependent DirectorLei LinIndependent DirectorYalin WuIndependent DirectorMore Executives SYUT Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Synutra International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Synutra International investors own include Lifeway Foods (LWAY), Alliance Fiber Optic Products (AFOP), Telaria (TLRA), Yingli Green Energy (YGE), AcelRx Pharmaceuticals (ACRX), Abercrombie & Fitch (ANF), Angi (ANGI), Alliance Resource Partners (ARLP), (ARMH) (ARMH) and Array Technologies (ARRY). This page (NASDAQ:SYUT) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synutra International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.